The clinical use of curcumin on neurological disorders: An updated systematic review of clinical trials
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The clinical use of curcumin on neurological disorders: An updated systematic review of clinical trials
Authors
Keywords
-
Journal
PHYTOTHERAPY RESEARCH
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-09-16
DOI
10.1002/ptr.7273
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The effects of nano-curcumin supplementation on Th2/Tregulatory axis in migraine patients: a randomized, double-blind, placebo-controlled trial
- (2021) Mona Djalali et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
- (2021) Matthew J Page et al. BMJ-British Medical Journal
- Effects of curcuminoids on inflammatory and oxidative stress biomarkers and clinical outcomes in critically ill patients: A randomized double‐blind placebo‐controlled trial
- (2021) Hoda Zahedi et al. PHYTOTHERAPY RESEARCH
- The omega-3 and Nano-curcumin effects on vascular cell adhesion molecule (VCAM) in episodic migraine patients: a randomized clinical trial
- (2021) Mina Abdolahi et al. BMC Research Notes
- Curcumin: an inflammasome silencer
- (2020) Shima Hassanzadeh et al. PHARMACOLOGICAL RESEARCH
- Effects of nanocurcumin on inflammatory factors and clinical outcomes in critically ill patients with sepsis: A pilot randomized clinical trial
- (2020) Arash Karimi et al. European Journal of Integrative Medicine
- Anti-Neuroinflammatory Properties of n-3 Fatty Acids and Nano-Curcumin on Migraine Patients, from Cellular to Clinical Insight: A Randomized, Double Blind, and Placebo-Controlled Trial
- (2020) Niyaz Mohammadzadeh Honarvar et al. Endocrine Metabolic & Immune Disorders-Drug Targets
- The role of phytochemicals in sepsis: A mechanistic and therapeutic perspective
- (2020) Babak Alikiaii et al. BIOFACTORS
- Nanocurcumin improves regulatory T-cell frequency and function in patients with multiple sclerosis
- (2019) Sanam Dolati et al. JOURNAL OF NEUROIMMUNOLOGY
- The Neuromodulatory Effects of ω-3 Fatty Acids and Nano-Curcumin on the COX-2/ iNOS Network in Migraines: A Clinical Trial Study from Gene Expression to Clinical Symptoms
- (2019) Mina Abdolahi et al. Endocrine Metabolic & Immune Disorders-Drug Targets
- Benefits of curcumin in brain disorders
- (2019) Abid Bhat et al. BIOFACTORS
- The synergistic effects of nano-curcumin and coenzyme Q10 supplementation in migraine prophylaxis: a randomized, placebo-controlled, double-blind trial
- (2019) Mohammad Parohan et al. NUTRITIONAL NEUROSCIENCE
- Liposomal Curcumin Enhances the Effect of Naproxen in a Rat Model of Migraine
- (2019) Adriana E. Bulboacă et al. MEDICAL SCIENCE MONITOR
- The Combined Effects of ω -3 Fatty Acids and Nano-Curcumin Supplementation on Intercellular Adhesion Molecule-1 (ICAM-1) Gene Expression and Serum Levels in Migraine Patients
- (2018) Neda Soveyd et al. CNS & Neurological Disorders-Drug Targets
- A novel combination of ω-3 fatty acids and nano-curcumin modulates interleukin-6 gene expression and high sensitivity C-reactive protein serum levels in patients with migraine: a randomized clinical trial study
- (2018) Mina Abdolahi et al. CNS & Neurological Disorders-Drug Targets
- Nanocurcumin restores aberrant miRNA expression profile in multiple sclerosis, randomized, double-blind, placebo-controlled trial
- (2018) Sanam Dolati et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Zishenpingchan granules for the treatment of Parkinson’s disease: a randomized, double-blind, placebo-controlled clinical trial
- (2018) Can-Xing Yuan et al. Neural Regeneration Research
- Safety and Efficacy of Nanocurcumin as Add-On Therapy to Riluzole in Patients With Amyotrophic Lateral Sclerosis: A Pilot Randomized Clinical Trial
- (2018) Mona Ahmadi et al. Neurotherapeutics
- Telmisartan Ameliorates Astroglial and Dopaminergic Functions in a Mouse Model of Chronic Parkinsonism
- (2018) Sathiya Sekar et al. NEUROTOXICITY RESEARCH
- Nanocurcumin is a potential novel therapy for multiple sclerosis by influencing inflammatory mediators
- (2018) Sanam Dolati et al. Pharmacological Reports
- Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: A clinical review
- (2018) Mohammad Bagherniya et al. PHARMACOLOGICAL RESEARCH
- Turmeric (Curcuma longa ) and its major constituent (curcumin) as nontoxic and safe substances: Review
- (2018) Vahid Soleimani et al. PHYTOTHERAPY RESEARCH
- Localized delivery of curcumin into brain with polysorbate 80-modified cerasomes by ultrasound-targeted microbubble destruction for improved Parkinson's disease therapy
- (2018) Nisi Zhang et al. Theranostics
- The Problem of Curcumin and Its Bioavailability: Could Its Gastrointestinal Influence Contribute to Its Overall Health-Enhancing Effects?
- (2018) Adrian L Lopresti Advances in Nutrition
- Amyotrophic Lateral Sclerosis and Oxidative Stress: a Double-Blind Therapeutic Trial After Curcumin Supplementation
- (2018) Lucia Chico et al. CNS & Neurological Disorders-Drug Targets
- Naringenin protects against 1-methyl-4-phenylpyridinium- induced neuroinflammation and resulting reactive oxygen species production in SH-SY5Y cell line: An in Vitro model of parkinson's disease
- (2018) Murugan Sevanan et al. Pharmacognosy Magazine
- The synergistic effects of ω-3 fatty acids and nano-curcumin supplementation on tumor necrosis factor (TNF)-α gene expression and serum level in migraine patients
- (2017) Mina Abdolahi et al. IMMUNOGENETICS
- Curcumin as a potential candidate for treating hyperlipidemia: A review of cellular and metabolic mechanisms
- (2017) Yunes Panahi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Therapeutic potential of curcumin for multiple sclerosis
- (2017) Munibah Qureshi et al. NEUROLOGICAL SCIENCES
- Dose-dependent effect of Curcuma longa for the treatment of Parkinson's disease
- (2017) Xiao-Wei Ma et al. Experimental and Therapeutic Medicine
- Preemptive Analgesic and Antioxidative Effect of Curcumin for Experimental Migraine
- (2017) Adriana E. Bulboacă et al. Biomed Research International
- Curcumin affords neuroprotection and inhibits α-synuclein aggregation in lipopolysaccharide-induced Parkinson’s disease model
- (2017) Neha Sharma et al. INFLAMMOPHARMACOLOGY
- Curcumin as a multifaceted compound against human papilloma virus infection and cervical cancers: A review of chemistry, cellular, molecular, and preclinical features
- (2016) Manouchehr Teymouri et al. BIOFACTORS
- Protein folding alterations in amyotrophic lateral sclerosis
- (2016) Sonam Parakh et al. BRAIN RESEARCH
- Mitochondrial dysfunction and cell death in neurodegenerative diseases through nitroxidative stress
- (2016) Mohammed Akbar et al. BRAIN RESEARCH
- Protective effects of a natural product, curcumin, against amyloid β induced mitochondrial and synaptic toxicities in Alzheimer's disease
- (2016) P Hemachandra Reddy et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Role of microRNAs in the Therapeutic Effects of Curcumin in Non-Cancer Diseases
- (2016) Amir Abbas Momtazi et al. Molecular Diagnosis & Therapy
- Intratumoral Concentrations and Effects of Orally Administered Micellar Curcuminoids in Glioblastoma Patients
- (2016) Stephan Dützmann et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- The effects of virtual reality-based bilateral arm training on hemiplegic children’s upper limb motor skills
- (2016) Ji-Hye Do et al. NEUROREHABILITATION
- Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer’s disease
- (2015) K. G. Goozee et al. BRITISH JOURNAL OF NUTRITION
- Epigenetic impact of curcumin on stroke prevention
- (2014) Anuradha Kalani et al. METABOLIC BRAIN DISEASE
- Curcumin Inhibits Mitochondrial Injury and Apoptosis from the Early Stage in EAE Mice
- (2014) Jinzhou Feng et al. Oxidative Medicine and Cellular Longevity
- Curcumin mediates presenilin-1 activity to reduce β-amyloid production in a model of Alzheimer’s disease
- (2014) Zhang Xiong et al. Pharmacological Reports
- A Review on Antibacterial, Antiviral, and Antifungal Activity of Curcumin
- (2014) Soheil Zorofchian Moghadamtousi et al. Biomed Research International
- Integrated multi-cohort transcriptional meta-analysis of neurodegenerative diseases
- (2014) Matthew D Li et al. Acta Neuropathologica Communications
- Curcumin and neurodegenerative diseases
- (2013) Adriana Monroy et al. BIOFACTORS
- Coupling to a glioblastoma-directed antibody potentiates antitumor activity of curcumin
- (2013) Phyllis Langone et al. INTERNATIONAL JOURNAL OF CANCER
- Highly Stabilized Curcumin Nanoparticles Tested in an In Vitro Blood–Brain Barrier Model and in Alzheimer’s Disease Tg2576 Mice
- (2012) Kwok Kin Cheng et al. AAPS Journal
- Curcumin: A Potential Neuroprotective Agent in Parkinson's Disease
- (2012) R. B. Mythri et al. CURRENT PHARMACEUTICAL DESIGN
- Curcumin-loaded lipid-core nanocapsules as a strategy to improve pharmacological efficacy of curcumin in glioma treatment
- (2012) Alfeu Zanotto-Filho et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- The Mediterranean Diet Score and Mortality Are Inversely Associated in Adults Living in the Subarctic Region
- (2012) Gianluca Tognon et al. JOURNAL OF NUTRITION
- Curcumin Induces Nrf2 Nuclear Translocation and Prevents Glomerular Hypertension, Hyperfiltration, Oxidant Stress, and the Decrease in Antioxidant Enzymes in 5/6 Nephrectomized Rats
- (2012) Edilia Tapia et al. Oxidative Medicine and Cellular Longevity
- Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study
- (2012) John M Ringman et al. Alzheimers Research & Therapy
- Cost of disorders of the brain in Europe 2010
- (2011) Anders Gustavsson et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Bioconjugates of curcumin display improved protection against glutathione depletion mediated oxidative stress in a dopaminergic neuronal cell line: Implications for Parkinson’s disease
- (2010) G. Harish et al. BIOORGANIC & MEDICINAL CHEMISTRY
- REVIEW: Curcumin and Alzheimer's Disease
- (2010) Tsuyoshi Hamaguchi et al. CNS Neuroscience & Therapeutics
- Inflammation in neurodegenerative diseases
- (2010) Sandra Amor et al. IMMUNOLOGY
- Glutamoyl diester of the dietary polyphenol curcumin offers improved protection against peroxynitrite-mediated nitrosative stress and damage of brain mitochondria in vitro: implications for Parkinson’s disease
- (2010) Rajeswara Babu Mythri et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Enhanced Glutathione Efflux from Astrocytes in Culture by Low Extracellular Ca2+ and Curcumin
- (2010) Malin H. Stridh et al. NEUROCHEMICAL RESEARCH
- Phenolic Compounds Prevent Alzheimer’s Pathology through Different Effects on the Amyloid-β Aggregation Pathway
- (2009) Tsuyoshi Hamaguchi et al. AMERICAN JOURNAL OF PATHOLOGY
- The effect of curcumin (turmeric) onAlzheimer′s disease: An overview
- (2009) Shrikant Mishra et al. Annals of Indian Academy of Neurology
- Meta-Analysis of Alzheimer's Disease Risk with Obesity, Diabetes, and Related Disorders
- (2009) Louis A. Profenno et al. BIOLOGICAL PSYCHIATRY
- Protein Targets of Oxidative Damage in Human Neurodegenerative Diseases with Abnormal Protein Aggregates
- (2009) Anna Martínez et al. BRAIN PATHOLOGY
- Curcumin acts as anti-tumorigenic and hormone-suppressive agent in murine and human pituitary tumour cells in vitro and in vivo
- (2009) C Schaaf et al. ENDOCRINE-RELATED CANCER
- Six-Month Randomized, Placebo-Controlled, Double-Blind, Pilot Clinical Trial of Curcumin in Patients With Alzheimer Disease
- (2009) Larry Baum et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- P4-344: Oral curcumin for the treatment of mild-to-moderate Alzheimer's disease: Tolerability and clinical and biomarker efficacy results of a placebo-controlled 24-week study
- (2008) John M. Ringman et al. Alzheimers & Dementia
- Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer
- (2008) N. Dhillon et al. CLINICAL CANCER RESEARCH
- Curcumin (Diferuloylmethane) Inhibits Cell Proliferation, Induces Apoptosis, and Decreases Hormone Levels and Secretion in Pituitary Tumor Cells
- (2008) Matthew Miller et al. ENDOCRINOLOGY
- Potential role of curcumin in stroke prevention
- (2008) Bruce Ovbiagele Expert Review of Neurotherapeutics
- Curcumin: Preventive and Therapeutic Properties in Laboratory Studies and Clinical Trials
- (2007) Alexios S. Strimpakos et al. ANTIOXIDANTS & REDOX SIGNALING
- Curcumin treatment alleviates the effects of glutathione depletion in vitro and in vivo: Therapeutic implications for Parkinson's disease explained via in silico studies
- (2007) Balusamy Jagatha et al. FREE RADICAL BIOLOGY AND MEDICINE
- Alterations in mitochondrial respiratory functions, redox metabolism and apoptosis by oxidant 4-hydroxynonenal and antioxidants curcumin and melatonin in PC12 cells
- (2007) Haider Raza et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started